Roka Bio Science, Inc. ROKA
We take great care to ensure that the data presented and summarized in this overview for Roka BioScience, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ROKA
Top Purchases
Top Sells
About ROKA
Insider Transactions at ROKA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 03
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
201,617
-100.0%
|
$0
$0.68 P/Share
|
Sep 29
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
94,134
-31.85%
|
$0
$0.74 P/Share
|
Sep 28
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
380,542
-56.29%
|
$0
$0.72 P/Share
|
Sep 27
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
52,799
-7.24%
|
$0
$0.92 P/Share
|
Sep 26
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
74,802
-9.31%
|
$74,802
$1.03 P/Share
|
Aug 24
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,200
-1.62%
|
$13,200
$1.5 P/Share
|
Aug 23
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,100
-0.13%
|
$1,100
$1.5 P/Share
|
Aug 22
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,500
-0.67%
|
$5,500
$1.52 P/Share
|
Aug 21
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,980
-0.36%
|
$2,980
$1.49 P/Share
|
Aug 18
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
66,796
-7.48%
|
$66,796
$1.52 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders